The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr NA
start NA
end NA
ID NA
miRNA_name hsa-miR?143?3p
methods Western blot,etc.
regulated up
Function Description In summary, a PSMG3?AS1?miR?143?3p?COL1A1 regula?tory axis in breast cancer was indicated in the present study. PSMG3?AS1 served as an oncogenic lncRNA that facilitated the genesis and development of breast cancer, by functioning as a ceRNA, which regulated the expression of COL1A1, and also through directly sponging miR?143?3p. In the present study, PSMG3?AS1 was indicated to be a new potential thera?peutic target in breast carcinoma treatment. Invivo studies have revealed the important role of lncRNAs and miRNAs in tumors. For example, H19 was revealed to be associated with tumor development, progression, metastasis and drug resistance (41), and silencing of MALAT1 suppressed the proliferation of GSCs and invivo tumor growth by upregulating miR?129 and inhibiting SOX2 (42)
PMID 31661146
year 2020
Title Novel lncRNA PSMG3?AS1 functions as a miR?143?3p sponge to increase the proliferation and migration of breast cancer cells.
drug V
circulating X
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China